黑料不打烊

Home

R+I Services during 黑料不打烊 COVID-19 Closure

Published: 17 March 2020

Sent on behalf of Martha Crago, Vice-Principal (Research and Innovation)...

Reminder: Canada Research Continuity Emergency Fund (CRCEF)

Published: 10 November 2020

This is a reminder to all principal investigators to complete their Canada Research Continuity Emergency Fund Stage 3 claims as soon as possible.

Identification of the receptor for Lionfish venom

Published: 11 October 2019

Invention 2019-098 Identification of the receptor for Lionfish venom 聽 The receptor through which Lionfish venom excites nociceptors has been identified at 黑料不打烊 University. 聽 Market Need

黑料不打烊 spinoff Laurent Pharmaceuticals to begin clinical trial on COVID-19 treatment

Published: 9 April 2020

Company to run a Phase 2 clinical study with LAU-7b, a pro-resolving drug with potential antiviral properties against coronavirus

Pages

Subscribe to Staff RSS
Back to top